Healthcare2 min reading time
Red Queen Bio is using AI to design antibodies for future viruses, WSJ says
The Next Web
Read the full articleRed Queen Bio, backed by OpenAI, has raised $36M to develop AI-designed antibody drugs targeting viruses like bird flu, with clinical trials planned for 2027. The startup aims to rapidly scale biological defenses against future viral threats, including those potentially engineered by AI.

- This Startup Is Using AI to Fight Off a Future AI Pandemic· The Wall Street Journal



